The seventh edition of the FACT-JACIE International Standards for Haematopoietic Cellular Therapy Product Collection, Processing, and Administration was published on March 1, 2018, and was implemented beginning in June 2018. These Haematopoietic Cell Therapy Standards apply to haematopoietic progenitor cells, defined as self-renewing and/or multi-potent stem cells capable of maturation into any of the haematopoietic lineages, lineage-restricted pluri-potent progenitor cells, and committed progenitor cells from haematopoietic sources (bone marrow, umbilical cord blood, peripheral blood, or other tissue source). These Standards also include mononuclear cells, defined as nucleated cells from any haematopoietic tissue source (marrow, peripheral blood, umbilical cord, and placental blood) collected for therapeutic use other than as haematopoietic progenitor cells.